Glaritus

Glaritus

insulin glargine

Manufacturer:

Ambica

Distributor:

Zuellig

Marketer:

Multicare
Concise Prescribing Info
Contents
Insulin glargine
Indications/Uses
Treatment of type 1 or 2 DM in patients who require insulin for the control of hyperglycemia.
Dosage/Direction for Use
SC Maintenance in patient w/ type 1 diabetes 0.5-1 IU/kg/day. Patient w/ type 2 diabetes 0.3-0.6 IU/kg/day.
Contraindications
Special Precautions
Not intended for IV administration. Not for the treatment of diabetic ketoacidosis. Renal & hepatic impairment. Alteration of insulin requirements due to intercurrent conditions eg, illness, emotional disturbances or stress. May impair ability to drive or operate machinery. Pregnancy. Childn <6 yr.
Adverse Reactions
Hypoglycemia; edema; hyperglycemia & ketoacidosis; allergic reactions including local & systemic allergy; inj site reactions; insulin resistance; antibody production; temporary visual impairment (marked change in glycemic control) or worsening of diabetic retinopathy (intensification of insulin therapy w/ abrupt improvement of glycemic control).
Drug Interactions
Enhanced blood glucose-lowering effect & susceptibility to hypoglycemia w/ oral antidiabetics, ACE inhibitors, pentoxifylline, perhexiline, disopyramide, fibrates, fluoxetine, MAOIs, dextropropoxyphene, salicylates, sulfonamides. Reduced blood glucose-lowering effect & susceptibility to hyperglycemia w/ corticosteroids, danazol, diazoxide, diuretics, glucagon, INH, OCs, phenothiazine derivatives, somatotrophin, sympathomimetics (eg, epinephrine, salbutamol, terbutaline), thyroid hormones, PIs & atypical antipsychotics (eg, olanzapine & clozapine). Potentiated or weakened blood glucose-lowering effect w/ β-blockers, clonidine, lithium salts or alcohol. Occurrence of hypoglycemia sometimes followed by hyperglycemia w/ pentamidine. Reduced signs of adrenergic counter-regulation w/ guanethidine & reserpine.
ATC Classification
A10AE04 - insulin glargine ; Belongs to the class of long-acting insulins and analogues for injection. Used in the treatment of diabetes.
Presentation/Packing
Form
Glaritus soln for inj 100 IU/mL
Packing/Price
3 mL x 1's (P741.25/box)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in